Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for vaccines has been on the rise globally, and Kuwait is no exception. The Other Vaccines market in Kuwait has been developing at a steady pace due to various factors.
Customer preferences: Customers in Kuwait have shown a growing preference for vaccines that offer protection against a wide range of diseases. This has led to an increase in demand for combination vaccines that offer protection against multiple diseases in a single shot. Additionally, customers in Kuwait have also shown a preference for vaccines that offer long-lasting protection and require fewer doses.
Trends in the market: The Other Vaccines market in Kuwait has seen a significant increase in demand for vaccines that offer protection against infectious diseases such as Hepatitis A and B, Meningococcal disease, and Rabies. This is due to the increasing awareness among customers about the importance of vaccination and the need to protect themselves against these diseases. Furthermore, the COVID-19 pandemic has also led to an increase in demand for vaccines that offer protection against respiratory infections.
Local special circumstances: Kuwait has a high population density, with a large number of people living in urban areas. This has led to an increased risk of infectious diseases spreading rapidly. Additionally, the country has a large expatriate population, which has led to an increased demand for vaccines that offer protection against diseases that are prevalent in their home countries.
Underlying macroeconomic factors: Kuwait has a high-income economy, which has led to an increase in healthcare spending. The government has been investing heavily in the healthcare sector, which has led to an increase in the availability of vaccines. Additionally, the country has a well-established healthcare system, which has made it easier for customers to access vaccines.In conclusion, the Other Vaccines market in Kuwait has been developing at a steady pace due to various factors such as customer preferences, increasing awareness about the importance of vaccination, and a well-established healthcare system. The demand for vaccines that offer protection against infectious diseases and respiratory infections is expected to continue to increase in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
